PubMed · 16702186
Managing large cell lymphoma.
Abstract
Rituximab has greatly improved standard cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy, but prospects remain poor in patients with adverse risk factors. We need to know whether the addition of rituximab also improves the efficacy of more intensive treatments and how to use molecular profiling to guide us in introducing other novel agents.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
C Gisselbrecht, N Mounier. 2006. Managing large cell lymphoma.. https://doi.org/10.1093/annonc%2Fmdj991. https://pubmed.health/record/pubmed%3A16702186/managing-large-cell-lymphoma
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.